Skip to main content

Advertisement

SpringerLink
Log in

Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation

  • Original Article
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

Fever of unknown origin (FUO) and suspected focal infection or inflammation are challenging medical problems. The aim of this study was to assess the value of fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) in patients with FUO and patients with suspected focal infection or inflammation. All FDG PET scans ordered because of FUO or suspected focal infection or inflammation in the last 4 years were reviewed. These results were compared with the final diagnosis. Thirty-five FDG PET scans were performed in 35 patients with FUO. A final diagnosis was established in 19 patients (54%). Of the total number of scans, 37% were clinically helpful. The positive predictive value of FDG PET in these patients was 87% and the negative predictive value was 95%. Fifty-five FDG PET scans were performed in 48 patients with suspected focal infection or inflammation. A final diagnosis was established in 38 patients (82%). Of the total number of scans, 65% were clinically helpful. The positive predictive value of FDG PET in these 55 episodes of suspected infection or inflammation was 95% and the negative predictive value was 100%. It is concluded that FDG PET appears to be a valuable imaging technique in the evaluation of FUO and suspected focal infection or inflammation. Furthermore, FDG PET could become a useful tool for evaluating the effect of treatment of infectious and inflammatory processes that cannot reliably be visualised by conventional techniques. However, to assess the additional diagnostic value of this technique, prospective studies of FDG PET as part of a structured diagnostic protocol are warranted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Petersdorf RG, Beeson PB. Fever of unexplained origin: report on 100 cases. Medicine 1961; 40:1–30.

    CAS  Google Scholar 

  2. Petersdorf RG. Fever of unknown origin. An old friend revisited. Arch Intern Med 1992; 152:21–22.

    Article  CAS  PubMed  Google Scholar 

  3. de Kleijn EM, Vandenbroucke JP, van der Meer JW. Fever of unknown origin (FUO). I A. prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria. The Netherlands FUO Study Group. Medicine (Baltimore) 1997; 76:392–400

  4. Knockaert DC, Vanneste LJ, Vanneste SB, Bobbaers HJ. Fever of unknown origin in the 1980s. An update of the diagnostic spectrum. Arch Intern Med 1992; 152:51–55.

    Article  CAS  PubMed  Google Scholar 

  5. de Kleijn EM, van der Meer JW. Fever of unknown origin (FUO): report on 53 patients in a Dutch university hospital. Neth J Med 1995; 47:54–60.

    PubMed  Google Scholar 

  6. Blockmans D, Knockaert D, Maes A, De Caestecker J, Stroobants S, Bobbaers H, Mortelmans L. Clinical value of [(18)F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis 2001; 32:191–196.

    Article  CAS  PubMed  Google Scholar 

  7. De Winter F, Vogelaers D, Gemmel F, Dierckx RA. Promising role of 18-F-fluoro-d-deoxyglucose positron emission tomography in clinical infectious diseases. Eur J Clin Microbiol Infect Dis 2002; 21:247–257.

    Article  Google Scholar 

  8. Bar-Shalom R, Valdivia AY, Blaufox MD. PET imaging in oncology. Semin Nucl Med 2000; 30:150–185.

    CAS  PubMed  Google Scholar 

  9. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33:1972–1980.

    CAS  PubMed  Google Scholar 

  10. Brown RS, Leung JY, Fisher SJ, Frey KA, Ethier SP, Wahl RL. Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: I. Are inflammatory cells important? J Nucl Med 1995; 36:1854–1861.

    CAS  PubMed  Google Scholar 

  11. Tahara T, Ichiya Y, Kuwabara Y, Otsuka M, Miyake Y, Gunasekera R, Masuda K. High [18F]-fluorodeoxyglucose uptake in abdominal abscesses: a PET study. J Comput Assist Tomogr 1989; 13:829–831.

    CAS  PubMed  Google Scholar 

  12. Hoogendoorn EH, Oyen WJ, van Dijk AP, van der Meer JW. Pneumococcal aortitis, report of a case with emphasis on the contribution to diagnosis of positron emission tomography using fluorinated deoxyglucose. Clin Microbiol Infect 2003; 9:73–76.

    Article  CAS  PubMed  Google Scholar 

  13. Meller J, Altenvoerde G, Munzel U, Jauho A, Behe M, Gratz S, Luig H, Becker W. Fever of unknown origin: prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET. Eur J Nucl Med 2000; 27:1617–1625.

    CAS  PubMed  Google Scholar 

  14. Lorenzen J, Buchert R, Bohuslavizki KH. Value of FDG PET in patients with fever of unknown origin. Nucl Med Commun 2001; 22:779–783.

    CAS  PubMed  Google Scholar 

  15. Knockaert DC, Vanneste LJ, Bobbaers HJ. Recurrent or episodic fever of unknown origin. Review of 45 cases and survey of the literature. Medicine (Baltimore) 1993; 72:184–196.

    Google Scholar 

  16. Sugawara Y, Braun DK, Kison PV, Russo JE, Zasadny KR, Wahl RL. Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results. Eur J Nucl Med 1998; 25:1238–1243.

    Article  CAS  PubMed  Google Scholar 

  17. Stumpe KD, Dazzi H, Schaffner A, von Schulthess GK. Infection imaging using whole-body FDG-PET. Eur J Nucl Med 2000; 27:822–832.

    Article  CAS  PubMed  Google Scholar 

  18. Chacko TK, Zhuang H, Nakhoda KZ, Moussavian B, Alavi A. Applications of fluorodeoxyglucose positron emission tomography in the diagnosis of infection. Nucl Med Commun 2003; 24:615–624.

    Article  CAS  PubMed  Google Scholar 

  19. Rennen HJ, Boerman OC, Oyen WJ, Corstens FH. Imaging infection/inflammation in the new millennium. Eur J Nucl Med 2001; 28:241–252.

    Google Scholar 

  20. Sugawara Y, Gutowski TD, Fisher SJ, Brown RS, Wahl RL. Uptake of positron emission tomography tracers in experimental bacterial infections: a comparative biodistribution study of radiolabeled FDG, thymidine,l-methionine, 67Ga-citrate, and 125I-HSA. Eur J Nucl Med 1999; 26:333–341.

    Article  CAS  PubMed  Google Scholar 

  21. Guhlmann A, Brecht-Krauss D, Suger G, Glatting G, Kotzerke J, Kinzl L, Reske SN. Fluorine-18-FDG PET and technetium-99m antigranulocyte antibody scintigraphy in chronic osteomyelitis. J Nucl Med 1998; 39:2145–2152.

    CAS  PubMed  Google Scholar 

  22. De Winter F, van de WC, Vogelaers D, de Smet K, Verdonk R, Dierckx RA. Fluorine-18 fluorodeoxyglucose-position emission tomography: a highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections. J Bone Joint Surg Am 2001; 83-A:651–660.

  23. Zhuang H, Duarte PS, Pourdehand M, Shnier D, Alavi A. Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging. Clin Nucl Med 2000; 25:281–284.

    CAS  PubMed  Google Scholar 

  24. Kalicke T, Schmitz A, Risse JH, Arens S, Keller E, Hansis M, Schmitt O, Biersack HJ, Grunwald F. Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: results of histologically confirmed cases. Eur J Nucl Med 2000; 27:524–528.

    PubMed  Google Scholar 

  25. Blockmans D, Stroobants S, Maes A, Mortelmans L. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 2000; 108:246–249.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of General Internal Medicine, Department of Internal Medicine, University Medical Centre Nijmegen, The Netherlands

    Chantal P. Bleeker-Rovers & Jos W. M. van der Meer

  2. Department of Nuclear Medicine, University Medical Centre Nijmegen, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands

    Chantal P. Bleeker-Rovers, Frans H. M. Corstens & Wim J. G. Oyen

  3. Division of Medical Oncology, Department of Internal Medicine, University Medical Centre Nijmegen, The Netherlands

    Elisabeth M. H. A. de Kleijn

Authors
  1. Chantal P. Bleeker-Rovers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elisabeth M. H. A. de Kleijn
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Frans H. M. Corstens
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jos W. M. van der Meer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Wim J. G. Oyen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chantal P. Bleeker-Rovers.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bleeker-Rovers, C.P., de Kleijn, E.M.H.A., Corstens, F.H.M. et al. Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging 31, 29–37 (2004). https://doi.org/10.1007/s00259-003-1338-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-003-1338-3

Keywords

Search

Navigation